There is news of relief amid rising demand to vaccinate children to protect against the corona epidemic. The European Medicines Agency (EMA) on Friday approved SpikeVax, Moderna’s vaccine for children aged 12 to 17 years.European Union The US drug regulator EMA said it was found to be effective in a study conducted on 3,732 children to test the efficacy of the vaccine. In this case it can be used.
Vaccine’s efficacy has been found similar to that of adults – EMA
Hindustan TimesAccording to the EMA, 2,163 of the 3,732 children aged 12-17 years involved in the vaccine’s efficacy investigation were given the vaccine dose, while 1,073 children were given a placebo. Even the child did not become infected with the corona virus, while four children taking the placebo showed mild infections. In this case, it has been as effective as adults.
Two doses were given in a span of four weeks
The EMA reported that in a clinical trial of the Spikevax vaccine conducted on children, children were monitored for four weeks after the first dose of the vaccine. He was then monitored by giving him a second dose of the vaccine. Results
CHMP concludes on vaccine
The EMA said that based on the results of the study on the vaccine, the Committee for Medicinal Products for Human Use (CHMP) has concluded that the efficacy of the Spikevax vaccine is similar in adults and that it can be used on children 12-17 years of age. Similarly, common side effects such as pain and swelling at the injection site, headache, nausea, vomiting and fever have been reported. However, it got fixed after a few days. Unclear
Due to limited number of volunteers, serious side effects were not detected – EMA
The EMA said that the limited number of volunteers in the trial could not determine the serious and very serious side effects of the vaccine or estimate the risks of known side effects, such as inflammation of the heart muscle. The EMA stressed that adults The benefits of spikevax in adolescents outweigh the risks compared to the overall safety prescribed in the U.S. In such a situation, it can be used for the safety of teenagers.
Till now only Pfizer’s vaccine was being used
After the EMA approves Moderna’s vaccine, another vaccine option will be available for vaccination in children. So far, children are being vaccinated only in North America and Europe. Pfizer’s vaccine is being used in this. In such a situation, now the Food and Drug Administration of America has started considering using Moderna’s vaccine for children under 18 years of age.
Trial of two vaccines is going on children in India
Let us inform that clinical trials of Zydus Cadila and Bharat Biotech vaccines are going on in India on children. Recently, the government had told that the trial of Zydus Cadila has been completed and the trial of Bharat Biotech is going on. That too will be completed soon. After this, the government will prepare a policy for vaccination in children on the basis of approval. Let us tell you that in India, 525 children are being tested for Covaxin.
The post European Medicines Agency approves Moderna vaccine for 12-17 year olds appeared first on Dainik Bhaskar | Uttar Pradesh News, UP Dainikbhaskar.
